Akamis Bio

About:

Akamis Bio is a clinical-stage oncology company.

Website: https://www.akamisbio.com

Twitter/X: psioxus

Top Investors: ARCH Venture Partners, Bristol-Myers Squibb, Invesco, IP Group, Salica

Description:

Akamis Bio is a clinical-stage oncology company whose mission is to use its groundbreaking Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to improve the lives of cancer patients. To accomplish this goal, the company is developing a portfolio of solid tumor-targeted T-SIGn® therapeutics that will allow a patient's immune system to recognize, attack, and clear their cancer.